Industry watch archive
26th November 2025
Women have an increased likelihood of underdiagnosis and undertreatment of heart and circulatory disease, and are underrepresented in research studies compared to men. This gender disparity is greater than just clinical issues - it is a reflection of inadequacies in health policy according to the British Medical Journal (BMJ) article.
Women are projected to continue experiencing more disability-adjusted life years related to cardiovascular risk factors compared to men, and greater mortality rates from rheumatic heart diseases (BMJ, 2025).
Top food tech trends for 2026 and the future
10th November 2025
There is a decline in popularity of meat alternatives and plant-based meat but hybrid meat has potential for the future.
GLP-1 weight loss drugs are both an opportunity and a threat to the future food industry. They are a threat as they could reduce food sales due to inhibiting appetites. However, they are also an opportunity as new products can be created that appeal to people who use GLP-1s.
Companies that can target key bottlenecks in the food industry and work collaboratively with the food industry will have investment potential in the future.
10th November 2025
A new screening tool has been designed and validated to examine American peoples' access to healthy food from a study led by researchers at the Food is Medicine Institute at the Gerald J. and Dorothy R. Friedman School of Nutrition Science and Policy.
The new tool - the Nutrition Security Screener (NSS) zones in on whether people can obtain and eat nourishing foods which support health and help prevent disease on a regular basis.
22nd October 2025
Researchers have conducted a literature review on interventional trials examining non nutritive sweeteners (artificial sweeteners) and type 2 diabetes mellitus or obesity.
Both interventional and indirect interventional data found that substituting sugar sweetened beverages or energy-dense foods with artificially sweetened beverages or meal replacements improved weight and cardiometabolic health, including glycaemia.
Association of 37 markers of ultra-processing with all-cause mortality: a prospective cohort study in the UK Biobank
8th October 2025
This study investigated the association between specific markers of ultra-processing (MUPs) and all-cause mortality using a population-based, prospective cohort study which included 186,744 UK Biobank participants between 40 and 75 years old.
The study examined the individual associations of MUPs i.e. flavour, sweetener, emulsifier, and gelling agent with mortality as each may have a different impact on health outcomes.
8th October 2025
Markets which will offer healthy food will be set up in some of the most deprived areas in Glasgow in an effort to address food insecurity and obesity.
The University of Glasgow using a £1m three-year pilot project will investigate why many Glaswegians have a poor diet lacking in high fibre foods, fruit, and vegetables. This will be done along with local groups.
Dr Ada Garcia, who is leading the study, has stated "This has been an underlying issue in Glasgow for years, but there have been a lot of different actions going on trying to tackle it...'
24th September 2025
This survey, coordinated by Picker for the Care Quality Commission (CQC), examined patients' experiences of their hospital treatment that involved at least one overnight stay. The survey explored every aspect of their care from referral to after discharge from hospital.
The patients’ overall ratings of their care improved. Patients who rated their care as 9 out of 10 increased from 50.8% to 52.1%. However, 42% of people who had a planned hospital admission stated that they would have liked to have been admitted to hospital earlier. Also, 43% stated that their health became “a bit” or “much worse” whilst on the waiting list.
Skipping breakfast and its wide-ranging health consequences: A systematic review from multiple metabolic disruptions to socioeconomic factors
10th September 2025
The aim of the systematic review was to examine the impact of skipping breakfast across multiple health domains. This included diabetes, regulation of weight, composition of gut microbiome, neurodegenerative diseases, cardiovascular health, cancer, immunity, sleep cycles, psychiatric disorders, bone health, athletic performance, socioeconomic factors, and cognitive function.
The systematic review examined the literature from 2010 to 2025 and it evaluated 66 studies.
10th September 2025
The aim of the STEER study was to examine the real-world occurrence of major adverse cardiovascular event (MACE) while being treated with semaglutide or tirzepatide for chronic weight management in standard clinical practice in the United States.
Semaglutide 2.4 mg (Wegovy®) showed a 57% greater reduction in the risk of stroke, heart attack, or death from any cause, in people with overweight or obesity and cardiovascular disease who remained on the treatment in comparison to tirzepatide. The result was found to be significant.
If you or a colleague has ever experienced a claim against you in your professional role as a dietitian or nutritionist, you will know how stressful and worrying it can be. PI insurance protection can cover you against claims of negligence or breach of duty made by a client.
Specialist PI broker, Trafalgar Risk Management (TRM), has announced the extension of its comprehensive and competitive PI insurance protection to cover registered dietitians and nutritionists against such claims.
The cover is available with premium funding from www.trafalgarinsurance.co.uk.